Besides PCa, previous studies have found PSMA expression in the neovasculature of a wide variety of solid tumors including breast carcinoma, gynecological and head and neck cancers, renal cell carcinoma, colorectal cancer, glioblastoma, and gastric adenocarcinoma [10, 11, 12], suggesting that this target can be useful also in other tumor types, extending the range of application of the reagent described herein. The gene discussed is FOLH1; the disease is neoplasm.